2019
DOI: 10.1002/14651858.cd013424
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological interventions for osteoporosis in people with chronic kidney disease stages 3-5D

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…With the aging of the population, the incidence of osteoporotic fractures might be increased by approximately 25% in the next 10 years. Loss of bone mineral density (BMD) is the major diagnostic metrics of OP due to an imbalance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation in these patients ( 9 11 ). However, this diagnostic method is usually performed after the onset of the symptoms of osteoporotic patients, which might delay all the efforts at prevention and treatment.…”
Section: Introductionmentioning
confidence: 99%
“…With the aging of the population, the incidence of osteoporotic fractures might be increased by approximately 25% in the next 10 years. Loss of bone mineral density (BMD) is the major diagnostic metrics of OP due to an imbalance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation in these patients ( 9 11 ). However, this diagnostic method is usually performed after the onset of the symptoms of osteoporotic patients, which might delay all the efforts at prevention and treatment.…”
Section: Introductionmentioning
confidence: 99%